Navigation Links
SGX Pharmaceuticals Announces First Quarter Financial Results and Gives Pipeline Update
Date:5/13/2008

e hereof.

SGX PHARMACEUTICALS, INC.

CONSOLIDATED STATEMENTS OF OPERATIONS

(in thousands, except per share data)

(unaudited)

Three Months Ended

March 31,

2008 2007

Revenue:

Collaborations and

commercial agreements $15,001 $5,647

Grants 1,971 5,321

Total revenue 16,972 10,968

Operating expenses:

Research and development 11,349 10,018

General and administrative 2,121 2,233

Total operating expenses 13,470 12,251

Income (loss) from operations 3,502 (1,283)

Interest income and expense, net 219 185

Net income (loss) $3,721 $(1,098)

Net income (loss) per common share:

Basic $0.18 $(0.07)

Diluted $0.18 $(0.07)

Shares used to compute

basic and diluted net

income (loss) per common share:

Basic 20,530 15,228

Diluted 21,089 15,228

Three Months Ended Three Months Ended

March 31, 2008 (1) March 31, 2007 (1)

Stock- Stock-

based Reported based Reported

compensation GAAP compensation GAAP

non-GAAP expense results non-GAAP expense results

Net income (loss) $4,347 $(626) $3,721 $(109) $(989) $(1,098)

Basic net income

(loss) per common

share:
'/>"/>

SOURCE SGX Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
2. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
5. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
6. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
7. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
8. Poniard Pharmaceuticals Announces Participation in Upcoming Conferences
9. NovaQuest Advances Virtual Development Model With Strategic Investment in TOPIGEN Pharmaceuticals
10. Drug Royalty Corporation (DRC) Announces Acquisition Regarding PEG-INTRON(R) From Enzon Pharmaceuticals, Inc. (ENZN)
11. Sunesis Pharmaceuticals Announces Reorganization to Focus Resources and Build Value in Clinical-Stage Programs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... Yuma Regional Cancer Center Officially ... brings comprehensive cancer care to Yuma, Arizona. , ... Center has officially opened. A Mayo Clinic Care ... such as open, semi-private and private infusion rooms, ... Resource Center, hematology, rehabilitation center, a pain management ...
(Date:7/30/2014)... 2014  AtheroNova Inc. (OTCBB: AHRO), a biotech ... compounds to safely regress atherosclerotic plaque and improve ... partner, CardioNova, has accomplished first dosing of subjects ... lead compound, AHRO-001.  This Phase 1b trial will ... safety trial completed in February 2014, in which ...
(Date:7/30/2014)... CA (PRWEB) July 30, 2014 Adding ... their weighing boat special – Buy 2 ... free. This promotion will benefit lab technicians looking for ... Weighing boats are ideal for multiple applications including weighing ... a variety of choices including diamond-shaped, hexagonal, square, aluminum ...
(Date:7/29/2014)... hurdled a number of significant technological challenges in ... technology originally created for the James Webb Space ... Harvey Moseley, a scientist at NASA,s Goddard Space ... electrostatically actuated microshutter arrays that is, those ... as functional as the current technology,s magnetically activated ...
Breaking Biology Technology:Sate-of-the-Art Yuma Regional Cancer Center Officially Opens 2AtheroNova Announces Milestone with Initiation of Phase 1b Clinical Trial of AHRO-001 2AtheroNova Announces Milestone with Initiation of Phase 1b Clinical Trial of AHRO-001 3AtheroNova Announces Milestone with Initiation of Phase 1b Clinical Trial of AHRO-001 4Weighing Boat Promotion Now Available at Pipette.com, Major Pipette Distributor 2Revolutionary microshutter technology hurdles significant challenges 2Revolutionary microshutter technology hurdles significant challenges 3Revolutionary microshutter technology hurdles significant challenges 4
... , , , , , , ... , , Features and benefits , ... , Suitable for a broad range of cell lines , ... and DNA Quantity vs. Transfection Efficiency ") , ...
... , , , For purification of up to 10 mg ultrapure plasmid , ... gravity-flow anion-exchange tips for efficient , purification of plasmid DNA , , ... Features and benefits , , ... to that obtained by 2x CsCl-gradient centrifugation , ...
... , , , , For ultrafast purification of up to 750 ... Features and benefits , , ... ultrapure DNA , ... No risk of DNA pellet loss during precipitation , ...
Cached Biology Technology:SuperFect Transfection Reagent 2SuperFect Transfection Reagent 3HiSpeed Plasmid Kits 2
(Date:7/29/2014)... the remote UK overseas territory of Ascension Island, one ... something of a renaissance. , Writing in the journal ... of Exeter and Ascension Island Government Conservation Department report ... remote South Atlantic outpost has increased by more than ... As many as 24,000 nests are now estimated to ...
(Date:7/29/2014)... (UM SOD) and Medicine (UM SOM) jointly announced ... million grant award from the National Institute of ... Institutes of Health to study the causes, prevention ... which renews a previous $12 million five-year NIAID-funded ... research by studying chlamydial and gonorrheal diseases as ...
(Date:7/29/2014)... of preterm babies latest research from the University ... teenagers, the brains of many preterm children can perform almost ... conducted by the University,s Robinson Research Institute has ... brain injury in early life, their cognitive abilities as a ... , However, the results of the study, published in this ...
Breaking Biology News(10 mins):Major turtle nesting beaches protected in 1 of the UK's far flung overseas territories 2University of Maryland Schools of Dentistry and Medicine receive NIH grant 2University of Maryland Schools of Dentistry and Medicine receive NIH grant 3University of Maryland Schools of Dentistry and Medicine receive NIH grant 4Preterm children's brains can catch up years later 2
... 18, 2014)-- Baylor University researchers, in collaboration with ... evidence of the environment inhabited by the early ... Island, Kenya. The groundbreaking discovery provides additional information ... connection between habitat preferences and the early diversification ...
... Glorioso, III, PhD (University of Pittsburgh School of Medicine, ... herpes viruses as efficient vectors for delivering therapeutic genes ... accomplishments, he has received a Pioneer Award from ... Ann Liebert, Inc., publishers. Human Gene Therapy ...
... lifelong debate of nature versus nurture continuesthis time in ... the Journal of Communication found that a ... children who engaged in increased viewing of violent TV ... Helen Vossen, and Patti Valkenburg of the University of ...
Cached Biology News:Discovery by Baylor University researchers sheds new light on the habitat of early apes 2Discovery by Baylor University researchers sheds new light on the habitat of early apes 3Joseph Glorioso, Ph.D., receives Pioneer Award 2Genetics linked to children viewing high amounts of violent media 2
Mouse monoclonal [AE3] to Cytokeratin 1 - 8, prediluted ( Abpromise for all tested applications). Antigen: Tissue / cell preparation - Human epidermal cells. Entrez GeneID: 140807 Swiss P...
Rac 1/2/3/4 (S-18)...
... K+ Cl- Cotransporter-1 (KCC1). ... significant sequence homology with ... REACTIVITIES: The immunogen sequence ... human, mouse, porcine and ...
Anti-G-alpha-i 1 G-Protein Host: mouse monoclonal Species Reactivity: human, mouse, rat Applications: WB Storage: 4C...
Biology Products: